Study Seeking Patients with Schizophrenia

  • STATUS
    Recruiting
  • sponsor
    Forest
Updated on 8 November 2020

Summary

Study Seeking Patients with Schizophrenia

Description

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophre

Details
Clinical Study IdentifierTX148429
SponsorForest
Last Modified on8 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 55 yrs?
Gender: Male or Female
Male or Female 18 to 55 years inclusive
BMI of 18-30 kg/m2
Have DSM 5 Diagnosis of Schizophrenia and symptomatically stable
Subject has maintained a stable body weight (change < 5%) for at least 3 months prior to visit 1 based on self report

Exclusion Criteria

First antipsychotic treatment within the past 12 months or < 1 year has elapsed since the onset of SCPT
History of poor or inadequate response to Olanzapine (Zyprexa)
Positive UDS except THC
Use of any Opioid agonist (codeine, oxycodone, tramadol, morphine) within 14 days prior to Visit 1 and or need to take opioid medication during study
Currently on statin (high cholesterol) medication that has been initiated or dose adjustment in last 3 months
Taking weight loss or hypoglycemic (diabetes medication) agents
Any GI procedures within 1 year prior to Visit 1 or any surgical procedure for weight loss
History of diabetes
Hepatitis B, C, or HIV
Previous clinical trial participation within 3 months of Visit 1
Participation in trial using ALK3831 (Alk-302, Alk 401)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note